Skip to content

Clinical trials

Phase 2 Leiomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 2 Country / region: United States Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20065
20072
20082
20093
20122
20152
20162
20172
20181
20194
20203
20214
20222
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting5
Recruiting5
Terminated5
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center7
National Cancer Institute (NCI)6
Brown University2
Dana-Farber Cancer Institute2
Herbert Irving Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
Massachusetts General Hospital2
Sarcoma Alliance for Research through Collaboration2
Alexander Z. Wei, MD1
Astex Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma46
Sarcoma29
Liposarcoma19
Histiocytoma, Malignant Fibrous15
Sarcoma, Synovial15
Hemangiosarcoma12
Fibrosarcoma10
Rhabdomyosarcoma9
Neurofibrosarcoma8
Dermatofibrosarcoma7

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.